arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

GSK plc

GSK Health Care Biotechnology: Pharmaceutical Preparations
$51.46
Today
as of Aug 5, 16:49 ET
Last 30 days -1.98% Jun 26 → Aug 05
$49.75 $50.81 $51.88 $52.94 $54.00 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$51.42
High
$51.97
Low
$51.27
Volume
$4M
Avg Vol
$5M
Mkt Cap
$108.7B
P/E (TTM)
—
Beta
—
52w High
$61.70
52w Low
$35.45
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

lean bull ▲ 9 ● 16 ▼ 0
Aug 1 · 06:15 Simply Wall St. neutral
GSK (LSE:GSK) Opens Cambridge Research Hub And Teams Up With Relation Therapeutics
Jul 30 · 01:03 GuruFocus.com neutral
GSK PLC (GSK) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Accelerated Pipeline ...
Jul 29 · 15:52 EARNINGS Zacks bullish
GSK Beats Q2 Earnings & Revenue Estimates, Announces Cost-Saving Plan
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$35
$62
61% of range
Avg surprise (last 2)
+7.2%
Avg reaction (last 1)
+2.3%
100% positive
Latest IV / EM
89%
EM ±5.2% · $51 · Aug 7

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.08$1.12$1.16$1.19$1.23 Actual $1.13Est $1.08Actual $1.23Est $1.12 Mar/2025Jun/2025

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 30, 2025Jun/2025 $1.23 $1.12 +9.8% — — earnings
Wed Apr 30, 2025Mar/2025 $1.13 $1.08 +4.6% — +2.3% earnings

Implied volatility — last 90 days

25%41%57%72%88% Jun 07 — IV 36% · EM ±3.4%Jun 08 — IV 35% · EM ±2.9%Jun 09 — IV 37% · EM ±2.7%Jun 10 — IV 43% · EM ±2.5%Jun 15 — IV 44% · EM ±3.2%Jun 16 — IV 32% · EM ±1.9%Jun 17 — IV 34% · EM ±1.4%Jun 19 — IV 27% · EM ±3.0%Jun 22 — IV 29% · EM ±2.4%Jun 23 — IV 28% · EM ±2.0%Jun 24 — IV 45% · EM ±2.6%Jun 25 — IV 37% · EM ±1.5%Jun 29 — IV 36% · EM ±8.4%Jun 30 — IV 34% · EM ±7.9%Jul 01 — IV 41% · EM ±9.4%Jul 02 — IV 32% · EM ±7.2%Jul 03 — IV 32% · EM ±7.2%Jul 06 — IV 34% · EM ±7.2%Jul 07 — IV 35% · EM ±7.1%Jul 08 — IV 36% · EM ±7.2%Jul 09 — IV 34% · EM ±6.6%Jul 10 — IV 34% · EM ±6.6%Jul 13 — IV 37% · EM ±6.5%Jul 14 — IV 38% · EM ±6.5%Jul 15 — IV 37% · EM ±6.2%Jul 16 — IV 38% · EM ±6.1%Jul 17 — IV 38% · EM ±5.9%Jul 20 — IV 40% · EM ±5.5%Jul 21 — IV 41% · EM ±5.4%Jul 22 — IV 42% · EM ±5.2%Jul 23 — IV 46% · EM ±5.4%Jul 24 — IV 46% · EM ±5.1%Jul 27 — IV 51% · EM ±4.2%Jul 28 — IV 32% · EM ±2.3%Jul 29 — IV 37% · EM ±2.2%Jul 30 — IV 25% · EM ±1.1%Aug 03 — IV 35% · EM ±3.0%Aug 04 — IV 34% · EM ±2.4%Aug 05 — IV 89% · EM ±5.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in